Ventas, Inc.
Ventas, Inc.
Your view on VTR
Overview
What the company does, where it operates, and who runs it.
About Ventas, Inc.
- Industry
- REIT - Healthcare Facilities
- Sector
- Real Estate
- CEO
- Debra A. Cafaro
- Headquarters
- 353 North Clark Street, Chicago, IL, US
- Industry
- REIT - Healthcare Facilities
- Sector
- Real Estate
- CEO
- Debra A. Cafaro
- Headquarters
- 353 North Clark Street, Chicago, IL, US
Ventas, an S&P 500 company, operates at the intersection of two powerful and dynamic industries: healthcare and real estate.
As one of the world's foremost Real Estate Investment Trusts (REIT), we use the power of capital to unlock the value of real estate, partnering with leading care providers, developers, research and medical institutions, innovators and healthcare organizations whose success is buoyed by the demographic tailwind of an aging population.
For more than twenty years, Ventas has followed a successful strategy that endures: combining a high-quality diversified portfolio of properties and capital sources to manage through cycles, working with industry leading partners, and a collaborative and experienced team focused on producing consistent growing cash flows and superior returns on a strong balance sheet, ultimately rewarding Ventas shareholders.
As of September 30, 2020, Ventas owned or managed through unconsolidated joint ventures approximately 1,200 properties.
Stock Data
Price chart, volume, and trading data.
What moved it
FRC Fair Value Algorithm
What the FRC Fair Value algorithm says it is worth vs. the current price — FRC's own, on every stock.
About this section
Fair value for Ventas, Inc. from FRC's valuation model, read against the market price. VTR last traded at $88.90, 164.5× trailing earnings — the estimate is read against that market price. The model runs on every stock on the platform and shows the estimate per share and the date it was calculated. A free account covers 3 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
About this section
Valuation, profitability, liquidity and leverage ratios for Ventas, Inc.. Starting points for Ventas, Inc.: P/E 164.5, EPS $0.52, beta 0.77 — an REIT - Healthcare Facilities name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
About this section
Dividend history, yield and payout sustainability for Ventas, Inc.. Ventas, Inc. paid $2.04 per share over the last year — a 2.3% yield at the current $88.90 price. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
About this section
Reported vs. expected earnings history for Ventas, Inc.. Trailing twelve-month EPS for Ventas, Inc. stands at $0.52. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Wall Street Analyst Estimates
Analysts' price targets, ratings, and revenue and EPS estimates.
Price targets, ratings and estimates published by outside analysts. Not FRC research, not a recommendation, and not the FRC Fair Value: that is FRC's proprietary model, built on the cash a company generates.
Current price
—
live quote
Analysts' target
$97.38
average of 16 firms, last 12 months
Analyst Ratings
- Strong Buy0
- Buy10
- Hold3
- Sell0
- Strong Sell0
Earnings Estimate
| EPS | Current QtrDec 2026 | Next QtrMar 2027 | Current YearFY Dec 2026 | Next YearFY Dec 2027 |
|---|---|---|---|---|
| Avg. estimate | $0.13 | $0.15 | $0.51 | $0.77 |
| Low estimate | $0.13 | $0.14 | $0.51 | $0.74 |
| High estimate | $0.13 | $0.15 | $0.52 | $0.79 |
| No. of analysts | 4 | 3 | 6 | 6 |
| Year-ago EPS | $0.15 | $0.11 | $0.541 | — |
| Growth | -12.9% | +31.8% | — | — |
1Year-ago EPS includes one-time items; growth not shown.
Revenue Estimate
| Revenue | Current QtrDec 2026 | Next QtrMar 2027 | Current YearFY Dec 2026 | Next YearFY Dec 2027 |
|---|---|---|---|---|
| Avg. estimate | $1.84B | $1.91B | $7.01B | $7.83B |
| Low estimate | $1.81B | $1.84B | $6.86B | $7.49B |
| High estimate | $1.86B | $1.99B | $7.12B | $8.06B |
| No. of analysts | 3 | 2 | 3 | 3 |
| Year-ago revenue | $1.57B | $1.66B | $5.83B | — |
| Growth | +17.6% | +15.2% | +20.2% | — |
Source: Wall Street analysts' published price targets, ratings and estimates, compiled by Financial Modeling Prep from StreetInsider, Benzinga; as of Nov 18, 2026. Not FRC research or a recommendation.
Financial Statements
Income statement, balance sheet, and cash flow statements.
About this section
Income statement, balance sheet and cash flow history for Ventas, Inc.. Ventas, Inc. has reported as a listed company since 1997. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Peer companies
Market cap
- AHRAmerican Healthcare REIT, Inc.REIT - Healthcare Facilities$13.5B
- CTRECareTrust REIT, Inc.REIT - Healthcare Facilities$9.6B
- DOCHealthpeak Properties, Inc.REIT - Healthcare Facilities$13.7B
- LTCLTC Properties, Inc.REIT - Healthcare Facilities$2.4B
- MPTMedical Properties Trust, Inc.REIT - Healthcare Facilities$883M
- NHINational Health Investors, Inc.REIT - Healthcare Facilities$3.0B
- NHPNational Healthcare Properties, Inc. (NHP)REIT - Healthcare Facilities$1.1B
- OHIOmega Healthcare Investors, Inc.REIT - Healthcare Facilities$14.3B
More REIT - Healthcare Facilities companies
ETFs holding Ventas, Inc.
% of the fund
- VNQVanguard Real Estate ETF$35.9B in assets2.24%
- VOOVanguard S&P 500 ETF$1.0T in assets0.07%
- VTIVanguard Total Stock Market ETF$689.2B in assets0.06%
- VOVanguard Mid-Cap ETF$103.4B in assets0.42%
- REZiShares Residential and Multisector Real Estate ETF$840M in assets6.88%
- JPREJPMorgan Realty Income ETF$483M in assets4.91%
- VGSRVert Global Sustainable Real Estate ETF$510M in assets4.54%
- ICFiShares Select U.S. REIT ETF$2.0B in assets4.46%
Largest holders first, then the funds most concentrated in VTR.
Institutional Ownership
Which funds and firms own the stock.
About this section
Which institutions hold Ventas, Inc., and how their positions are changing. At a $47.01B market value, institutional positions materially move Ventas, Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings.
Insider Trading
Recent buying and selling by company executives.
About this section
Buying and selling by Ventas, Inc. executives and directors. Shares of Ventas, Inc. have traded between $56.68 and $80.29 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.
Senate Trading
U.S. Senator disclosures filed under the STOCK Act.
About this section
U.S. Senate disclosures naming Ventas, Inc.. Ventas, Inc. is a $47.01B Real Estate company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely.
House Trading
U.S. Representative disclosures filed under the STOCK Act.
About this section
U.S. House of Representatives disclosures naming Ventas, Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals.
News
Latest headlines and market coverage.
About this section
Latest headlines and company announcements for Ventas, Inc.. Coverage tracks Ventas, Inc. within REIT - Healthcare Facilities (Real Estate). Press releases and market coverage, newest first.

Comments
Comments and replies from FRC members about this company.
No comments yet
Be the first to ask a question or say what you make of Ventas, Inc.